Prof. Dr. med. Daniel Paris, Associate Professor, MD, PhD, DTMH

Function(s)
Medical Director,
Head of Department

Organisational Entity
Medicine

Daniel Paris, MD, PhD, DTMH, is a clinical doctor, Associate Professor and Medical Director and Head of the Department of Medicine at Swiss TPH. His position incorporates the fusion of two predominantly service-oriented departments into a single medical department, with the addition of clinical translational research and diagnostic methodologies. Paris is a Swiss national, clinically trained at the University of Zurich. He spent many years working in clinical research in Southeast Asia for the University of Oxford, based in Bangkok as coordinator of clinical tropical medicine research with a focus on tropical rickettsial illnesses, diagnostics, clinical trials and causes-of-fever studies.

Latest Publications

All Publications

Brummaier T et al. Improved detection of intestinal helminth infections with a formalin ethyl-acetate-based concentration technique compared to a crude formalin concentration technique. Trop Med Infect Dis. 2021;6(2):51. DOI: 10.3390/tropicalmed6020051

Brummaier T et al. Burden of soil-transmitted helminth infection in pregnant refugees and migrants on the Thailand-Myanmar border: results from a retrospective cohort. PLoS Negl Trop Dis. 2021;15(3):e0009219. DOI: 10.1371/journal.pntd.0009219

Elliott I et al. Targeted capture and sequencing of Orientia tsutsugamushi genomes from chiggers and humans. Infect Genet Evol. 2021;91:104818. DOI: 10.1016/j.meegid.2021.104818

Kahlig P, Neumayr A, Paris D.H. Louse-borne relapsing fever-a systematic review and analysis of the literature: part 2-mortality, jarisch-herxheimer reaction, impact on pregnancy. PLoS Negl Trop Dis. 2021;15(3):e0008656. DOI: 10.1371/journal.pntd.0008656

Kahlig P, Paris D.H, Neumayr A. Louse-borne relapsing fever-a systematic review and analysis of the literature: part 1-epidemiology and diagnostic aspects. PLoS Negl Trop Dis. 2021;15(3):e0008564. DOI: 10.1371/journal.pntd.0008564

Kümmerle A et al. Recognition and management of clinically significant drug-drug interactions between antiretrovirals and co-medications in a cohort of people living with HIV in rural Tanzania: a prospective questionnaire-based study. J Antimicrob Chemother. 2021(in press). DOI: 10.1093/jac/dkab254

Mapesi H et al. The coArtHA trial—identifying the most effective treatment strategies to control arterial hypertension in sub-Saharan Africa: study protocol for a randomized controlled trial. Trials. 2021;22:77. DOI: 10.1186/s13063-021-05023-z

Arpagaus A et al. Extrapulmonary tuberculosis in HIV-infected patients in rural Tanzania: the prospective Kilombero and Ulanga antiretroviral cohort. PLoS One. 2020;15(3):e0229875. DOI: 10.1371/journal.pone.0229875

Bircher R.E et al. High failure rates of protease inhibitor-based antiretroviral treatment in rural Tanzania - a prospective cohort study. PLoS One. 2020;15(1):e0227600. DOI: 10.1371/journal.pone.0227600

Brown J.A et al. Genotype-Informed Versus Empiric Management Of VirEmia (GIVE MOVE): study protocol of an open-label randomised clinical trial in children and adolescents living with HIV in Lesotho and Tanzania. BMC Infect Dis. 2020;20:773. DOI: 10.1186/s12879-020-05491-9